CPHI stock: buy or sell?
April 6th, 2020
China Pharma Holdings, Inc. develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People's Republic of China.
Should I buy CPHI stock?Make a decision about when to buy or sell stocks is one of the hardest parts of being a trader or investor. Trading strategies are meant for helping you in the decision process of what stocks to pick and when is the best moment to buy them. There are thousands of trading strategies for you to choose, but at Stocks2.com we prefer those that are simple but successful.
Currently, China Pharma stock doesn't match any of these trading strategies, so our recommendation is not to buy.
|New all-time high||No|
|New 52 week high||No|
|Price crossing up 200d MA||No|
|100d MA crossing up 200d MA||No|
Is China Pharma stock a buy?
Banks and financial institutions post stock ratings everyday.Unfortunately, we couldn't find any rating for CPHI stock for the last month.
CPHI stock analysis
Shares of China Pharma plunged a dreadful -4.88% and closed at $0.39.
China Pharma plunged a dreadful -4.88% and closed at $0.39. Since February when SMA100d and SMA200d crossed up, CPHI price slipped $-0.13 per share (-25.00%). Since last January when CPHI stock price broke up the SMA200d line, it gained $0.11 (39.29%).
China Pharma plummed a terrible -4.88% this week. Late March CPHI boosted an extraordinary 9.52% in just one week.
Price pattern shows an uptrend with two rising tops and bottoms, and now trading upwards to the $1.40 resistance. Since early February when SMA20w and SMA40w crossed up, CPHI price slipped $-0.08 per share (-17.02%). Since early January when CPHI stock price broke up the SMA40w line, it gained $0.12 (44.44%).
CPHI stock price history
CPHI stock went public on June 19th, 2002 with a price of $2.831. Since then, CPHI stock lost a -86.20%, with a yearly average of -5.10%.
1: Adjusted price after possible price splits or reverse-splits.
CPHI stock historical price chart
CPHI stock reached 52-week highs on March 2nd at $1.40, and all-time highs 2003-08-14 with a price of 7.63.
CPHI stock price targetHow much a stock will be priced tomorrow or next week is quite unpredictable However, financial institutions invest time and resources to provide the most accurated estimations to help investors to make their decisions. We do not recommend to follow these stock price predictions without a critical thinking from your side, as their accuracy is usually low. For the last 30 days we have not detected any price prediction for China Pharma stock by any trusted analyst.
Financials and fundamental analysis
Earnings date and Earnings per Share, when China Pharma posted its last earnings report, it . As soon as we get its posted EPS from the earnings report, we will extend this review.
|Quarter||Reporting date||Estimated EPS||Actual EPS||Surprise|
Annual financial resultsIn 2018, China Pharma annual turnover slipped a rough -6.67% to $12.33 million USD from $13.21 marked in 2017. Improving that, its earnings margin (compared to sales) skyrocketed to -87.18%, that is $-10.75 million.
|2012||$55 M||-||$4.62 M8.5%||-|
|2013||$33 M||-39.81%||$-20.01 M-61.0%||-533.12%|
|2014||$25 M||-24.02%||$-26.05 M-104.5%||30.17%|
|2015||$20 M||-18.36%||$-15.41 M-75.7%||-40.86%|
|2016||$16 M||-23.49%||$-9.18 M-59.0%||-40.39%|
|2017||$13 M||-15.15%||$-19.28 M-145.9%||109.94%|
|2018||$12 M||-6.67%||$-10.75 M-87.2%||-44.23%|
Quarterly financial resultsChina Pharma reported $3.24 M in sales for 2018-Q4, a 41.09% improvement compared to previous quarter. Reported quarter income marked $-7.59 million with a profit margin of -234.12%. Profit margin plunged a -153.35% compared to previous quarter when profit margin was -80.77%. When comparing sales to same quarter last year, China Pharma sales marked a bloodcurdling correction and plummed a -15.72%.
|2017-Q1||$3 M||-||$-0.97 M-29.4%||-|
|2017-Q2||$3 M||-11.25%||$-2.29 M-78.4%||136.84%|
|2017-Q3||$3 M||8.30%||$-2.20 M-69.4%||-4.13%|
|2017-Q4||$4 M||21.68%||$-13.83 M-359.4%||529.82%|
|2018-Q1||$4 M||-6.03%||$-0.29 M-8.1%||-97.88%|
|2018-Q2||$3 M||-12.22%||$-1.01 M-31.8%||243.48%|
|2018-Q3||$2 M||-27.58%||$-1.86 M-80.8%||84.17%|
|2018-Q4||$3 M||41.09%||$-7.59 M-234.1%||308.94%|
China Pharma ownershipWhen you are planning to buy a company, it's always worth to overview its ownership structure.
Management staff in all public traded companies that hold equity is required to report every transaction to the SEC. For China Pharma, 49.66% of all outstanding shares are owned by its staff.
In case of China Pharma stock, 2.33% of its shares are held by institutions (mutual funds, pension funds, big banks and other large financial institutions). Bearish positions for CPHI stock account 0.00%, no big difference from last month.
The following table compares ownership indicators for other stocks related to China Pharma:
|Market cap||$17.0 M|
|Total shares||43.6 M|
|Float shares||21.9 M|
|- Institutional holdings (%)||2.3%|
|- Insider holdings (%)||49.7%|
|Shares in short selling||0.0%|
|Monday, April 6th, 2020|
|Day range||$0.36 - $0.42|
|Average true range||$0.10|
|50d mov avg||$0.58|
|100d mov avg||$0.42|
|200d mov avg||$0.35|
China Pharma performanceTo measure stock performance is always good to benchmark with competitors or related stocks. In the following table, we compare China Pharma performance to :